Orforglipron trials for Obesity

All Orforglipron trials · All Obesity trials

Phase breakdown

Recruiting trials studying Orforglipron for Obesity

• A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)
  NCT06672549 · Phase: Phase 3 · Ages: 6 Years to 17 Years · Sex: All (male and female) · 117 locations
• A Study of Orforglipron (LY3502970) in Adolescent Participants With Obesity, or Overweight With Related Comorbidities
  NCT06672939 · Phase: Phase 3 · Ages: 12 Years to 17 Years · Sex: All (male and female) · 34 locations
• A Study of Orforglipron (LY3502970) in Participants With Obesity or Overweight and Osteoarthritis (OA) of the Knee
  NCT07153471 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · 88 locations
• A Study of Orforglipron in Female Participants With Stress Urinary Incontinence Who Have Obesity or Overweight
  NCT07202884 · Phase: Phase 3 · Ages: 18 Years and older · Sex: Female · 136 locations
• IBI3042 Study in Healthy Participants and Overweight or Obese Participants
  NCT07793019 · Phase: Phase 1 · Ages: 18 Years to 55 Years · Sex: All (male and female) · 1 location

Common questions

How many trials study Orforglipron for Obesity?

5 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.